Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 40/100

Failure Rate

12.5%

1 terminated/withdrawn out of 8 trials

Success Rate

85.7%

-0.8% vs industry average

Late-Stage Pipeline

38%

3 trials in Phase 3/4

Results Transparency

0 of 6 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A

4(57.1%)

Phase 4

2(28.6%)

Phase 3

1(14.3%)

7Total

N/A(4)

Phase 4(2)

Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials

NCT04687267Completed

Conservative Management of CIN2 Lesions and Biomarkers Evaluation

Role: collaborator

NCT00161330Phase 3Terminated

Oral vs Initial Intravenous Antibiotic Treatment of Urinary Tract Infections in Children: a RCT

Role: collaborator

NCT01513980Not ApplicableCompleted

Life-long Monitoring of COPD in Veneto Region

Role: lead

NCT01569893Not ApplicableCompleted

Life-Long Monitoring of Diabetes Mellitus in Veneto Region

Role: lead

NCT01608932Not ApplicableCompleted

Life-long Monitoring of Frail Patients With Chronic Diseases

Role: lead

NCT01513993Not ApplicableCompleted

Remote Monitoring of Chronic Heart Failure in Veneto Region

Role: lead

NCT01195181Phase 4Completed

Different PEG-interferon and Ribavirin Schedules for Chronic Hepatitis C in the Real Clinical Practice.

Role: collaborator

NCT00156546Phase 4Unknown

Evaluation of the Effectiveness of Antibiotic Prophylaxis in Children With a Previous Urinary Tract Infection

Role: collaborator

All 8 trials loaded